News

The future of urban mobility is near. EU-backed trials of driverless cars in public transport could make Europe’s city ...
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced new data from the ...